First Citizens Bank & Trust’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.16M | Buy |
176,391
+47,885
| +37% | +$1.94M | 0.13% | 95 |
|
|
2025
Q1 | $5.63M | Buy |
128,506
+810
| +0.6% | +$35.5K | 0.14% | 99 |
|
|
2024
Q4 | $5.49M | Buy |
127,696
+55,643
| +77% | +$2.39M | 0.1% | 101 |
|
|
2024
Q3 | $3.2M | Buy |
72,053
+6,227
| +9% | +$276K | 0.07% | 154 |
|
|
2024
Q2 | $2.62M | Buy |
65,826
+1,709
| +3% | +$68K | 0.05% | 165 |
|
|
2024
Q1 | $2.77M | Buy |
64,117
+12,325
| +24% | +$532K | 0.05% | 160 |
|
|
2023
Q4 | $2.16M | Sell |
51,792
-6,647
| -11% | -$277K | 0.04% | 162 |
|
|
2023
Q3 | $2.32M | Buy |
58,439
+748
| +1% | +$29.7K | 0.05% | 142 |
|
|
2023
Q2 | $2.36M | Buy |
57,691
+13,588
| +31% | +$557K | 0.04% | 146 |
|
|
2023
Q1 | $1.81M | Buy |
44,103
+8,173
| +23% | +$335K | 0.04% | 153 |
|
|
2022
Q4 | $1.47M | Buy |
35,930
+662
| +2% | +$27.1K | 0.04% | 156 |
|
|
2022
Q3 | $1.42M | Sell |
35,268
-11,402
| -24% | -$458K | 0.05% | 156 |
|
|
2022
Q2 | $1.96M | Sell |
46,670
-1,660
| -3% | -$69.7K | 0.07% | 124 |
|
|
2022
Q1 | $2.19M | Buy |
48,330
+964
| +2% | +$43.6K | 0.09% | 122 |
|
|
2021
Q4 | $2.19M | Buy |
47,366
+1,628
| +4% | +$75.1K | 0.09% | 120 |
|
|
2021
Q3 | $2.17M | Sell |
45,738
-203
| -0.4% | -$9.63K | 0.1% | 114 |
|
|
2021
Q2 | $2.38M | Sell |
45,941
-1,500
| -3% | -$77.6K | 0.11% | 108 |
|
|
2021
Q1 | $2.39M | Sell |
47,441
-1,362
| -3% | -$68.6K | 0.11% | 119 |
|
|
2020
Q4 | $2.54M | Sell |
48,803
-862
| -2% | -$44.9K | 0.13% | 107 |
|
|
2020
Q3 | $2.16M | Sell |
49,665
-1,620
| -3% | -$70.5K | 0.15% | 119 |
|
|
2020
Q2 | $2.2M | Buy |
51,285
+5,836
| +13% | +$251K | 0.18% | 111 |
|
|
2020
Q1 | $1.64M | Buy |
45,449
+4,355
| +11% | +$157K | 0.2% | 112 |
|
|
2019
Q4 | $1.88M | Buy |
+41,094
| New | +$1.88M | 0.18% | 115 |
|